Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity

This publication has 39 references indexed in Scilit:

• Agonists of Toll-Like Receptors 3, 4, 7, and 9 Are Candidates for Use as Adjuvants in an Outer Membrane Vaccine againstNeisseria meningitidisSerogroup B
  Infection and Immunity, 2007
• The perfect mix: recent progress in adjuvant research
  Nature Reviews Microbiology, 2007
• Expression of the Lipopolysaccharide-Modifying Enzymes PagP and PagL Modulates the Endotoxic Activity ofBordetella pertussis
  Infection and Immunity, 2006
• Distinct Contributions of Vaccine-Induced Immunoglobulin G1 (IgG1) and IgG2a Antibodies to Protective Immunity against Influenza
  Clinical and Vaccine Immunology, 2006
• Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopes
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 2006
• Clinical experience with inactivated, virosomal influenza vaccine
  Vaccine, 2005
• Innate immune sensing and its roots: the story of endotoxin
  Nature Reviews Immunology, 2003
• Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration
  Vaccine, 2000
• Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients
  Vaccine, 1997
• A rapid and sensitive sub-micro phosphorus determination
  Analytica Chimica Acta, 1961